homepage_cover_1

Firm of Choice
for the Most Difficult
Legal Issues

homepage_cover_2

Cross-Border Capabilities
with a China Edge

News

Fangda advised AnHeart Therapeutics in Nuvation Bio’s acquisition in an all-stock transaction

Insight

Antitrust China Annual Review 2023
Our annual review examines ten significant trends in China's antitrust landscape in 2023 and presents the forecasts for 2024.

Awards & Rankings

The Legal 500 Asia-Pacific 2024
Tier 1 Rankings

Chambers Greater China Region Guide 2023
Band 1 Rankings